Stock-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2022

Share-based Payment Arrangement [Abstract]

Schedule of Stock-Based Compensation Expense

We recognized total stock-based compensation expense in our Condensed Consolidated Statements of Operations as follows (in thousands):

	Three months ended March 31,
	2022		2021
Cost of goods sold	$	669	$	727
Research and development	12,041		14,162
General and administrative	8,251		9,009
Total stock-based compensation	$	20,961	$	23,898

Schedule of Share-based Compensation, Activity

We issued stock-based awards of our common stock as follows (shares in thousands):

	Three months ended March 31,
	2022		2021
Options granted	22		121
Weighted-average grant-date fair value of options granted	$	6.61	$	10.82
RSUs granted	405		367
Weighted-average grant-date fair value of RSUs granted	$	9.39	$	20.63